Literature DB >> 22861371

Experimentally induced psoriatic lesion associates with interleukin (IL)-6 in mast cells and appearance of dermal cells expressing IL-33 and IL-6 receptor.

M-M Suttle1, G Nilsson, E Snellman, I T Harvima.   

Abstract

Mast cells are involved in the development of psoriatic lesion, but it is not known how mast cells are activated or whether mast cell cytokines are expressed during the lesion development. In this study, the Köbner reaction was induced in uninvolved psoriatic skin of 18 patients using the tape-stripping technique, and a sequence of biopsies was collected at 0 days, 2 h and 3 days or at 0 days, 1 day and 7 days for histochemical analysis. Eight patients developed the Köbner reaction verified at the follow-up visit 2-2·5 weeks later. No significant differences were observed in total tryptase(+) mast cells, psoriasis area and severity index and age/sex. Instead, the percentage of tryptase(+) mast cells showing interleukin (IL)-6 immunoreactivity was significantly higher in biopsies from Köbner-positive patients than in those from Köbner-negative patients. IL-33 is a known inducer of IL-6 in mast cells, and the number of IL-33(+) cells increased significantly in Köbner-positive dermal skin at days 3-7. The number of dermal cells with IL-6 receptor (IL-6R, CD126) also increased in Köbner-positive skin at days 3-7. Unexpectedly, the number of IL-6R(+) cells was even higher in Köbner-negative skin at days 3-7. In the chronic plaque of 10 other psoriatic patients, the numbers of IL-6(+) mast cells and dermal cells showing IL-6R were higher than those in the non-lesional skin. In conclusion, the positive Köbner reaction is associated with IL-6 in mast cells and appearance of IL-6R(+) and IL-33(+) dermal cells. This suggests that a previously unrecognized vicious circle may develop in the early psoriatic lesion.
© 2012 The Authors. Clinical and Experimental Immunology © 2012 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22861371      PMCID: PMC3445008          DOI: 10.1111/j.1365-2249.2012.04618.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  45 in total

Review 1.  Mast cells as initiators of immunity and host defense.

Authors:  B M Henz; M Maurer; U Lippert; M Worm; M Babina
Journal:  Exp Dermatol       Date:  2001-02       Impact factor: 3.960

2.  Mast cells in the initial stages of psoriasis.

Authors:  B Toruniowa; S Jabłońska
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

3.  The natural history of psoriasis in 5,600 patients.

Authors:  E M Farber; M L Nall
Journal:  Dermatologica       Date:  1974

4.  Mast cells and macrophages in early relapsing psoriasis.

Authors:  C Schubert; E Christophers
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

5.  Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.

Authors:  R M Grossman; J Krueger; D Yourish; A Granelli-Piperno; D P Murphy; L T May; T S Kupper; P B Sehgal; A B Gottlieb
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

6.  Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4.

Authors:  A Lorentz; S Schwengberg; G Sellge; M P Manns; S C Bischoff
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

7.  The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response.

Authors:  K Uyemura; M Yamamura; D F Fivenson; R L Modlin; B J Nickoloff
Journal:  J Invest Dermatol       Date:  1993-11       Impact factor: 8.551

8.  Mast cell tryptase and chymase in developing and mature psoriatic lesions.

Authors:  I T Harvima; A Naukkarinen; K Paukkonen; R J Harvima; M L Aalto; L B Schwartz; M Horsmanheimo
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

9.  Mast cell degranulation in the evolution of acute eruptive guttate psoriasis vulgaris.

Authors:  I Brody
Journal:  J Invest Dermatol       Date:  1984-05       Impact factor: 8.551

10.  Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase.

Authors:  H Mizutani; N Schechter; G Lazarus; R A Black; T S Kupper
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  8 in total

1.  T cells and cytokines in inflamed psoriatic skin. Who's in charge?

Authors:  Simon Milling; Stefan Siebert
Journal:  Immunology       Date:  2020-08       Impact factor: 7.397

2.  Interleukin-33 alleviates psoriatic inflammation by suppressing the T helper type 17 immune response.

Authors:  Zeyu Chen; Yifan Hu; Yu Gong; Xilin Zhang; Lian Cui; Rongfen Chen; Yingyuan Yu; Qian Yu; Youdong Chen; Hongyue Diao; Jia Chen; Yuanyuan Wang; Yuling Shi
Journal:  Immunology       Date:  2020-05-25       Impact factor: 7.397

3.  Interleukin 22 and 6 serum concentrations decrease under long-term biologic therapy in psoriasis.

Authors:  Irmina Olejniczak-Staruch; Joanna Narbutt; Igor Bednarski; Anna Woźniacka; Joanna Sieniawska; Marzena Kraska-Gacka; Janusz Śmigielski; Aleksandra Lesiak
Journal:  Postepy Dermatol Alergol       Date:  2020-11-07       Impact factor: 1.837

Review 4.  IL-6 as a druggable target in psoriasis: focus on pustular variants.

Authors:  Andrea Saggini; Sergio Chimenti; Andrea Chiricozzi
Journal:  J Immunol Res       Date:  2014-07-13       Impact factor: 4.818

Review 5.  Possible Roles of IL-33 in the Innate-Adaptive Immune Crosstalk of Psoriasis Pathogenesis.

Authors:  Serafinella Patrizia Cannavò; Lucrezia Bertino; Eleonora Di Salvo; Valeria Papaianni; Elvira Ventura-Spagnolo; Sebastiano Gangemi
Journal:  Mediators Inflamm       Date:  2019-10-14       Impact factor: 4.711

6.  Relevance of Inflammatory Cytokine mRNA Expression of Tumour Necrosis Factor- Alpha (TNF α), Interleukin 17A (IL 17A) and Interleukin 6 (IL 6) in Indian Patients with Psoriasis.

Authors:  Saiqa R Shah; Sadiya B Shaikh; Yashodhar P Bhandary; Shaheena Yassir; Manjunath M Shenoy
Journal:  Indian Dermatol Online J       Date:  2022-03-03

7.  A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ.

Authors:  Yuval Ramot; Koji Sugawara; Nóra Zákány; Balázs I Tóth; Tamás Bíró; Ralf Paus
Journal:  PeerJ       Date:  2013-02-19       Impact factor: 2.984

Review 8.  Koebner phenomenon leading to the formation of new psoriatic lesions: evidences and mechanisms.

Authors:  Yong-Zhi Ji; Shi-Rui Liu
Journal:  Biosci Rep       Date:  2019-12-20       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.